Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
32836-1-PBS targets ITFG2 in WB, Indirect ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag36829 Product name: Recombinant human ITFG2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 210-362 aa of BC006552 Sequence: LLCTWKKDTGSPPASEGPTDGSRETPAARDVVLHQTSGRIHNKNVSTHLIGNIKQGHGTESSGSGLFALCTLDGTLKLMEEMEEADKLLWSVQVDHQLFALEKLDVTGNGHEEVVACAWDGQTYIIDHNRTVVRFQVDENIRAFCAGLYACKE 相同性解析による交差性が予測される生物種 |
| Full Name | integrin alpha FG-GAP repeat containing 2 |
| Calculated molecular weight | 49 kDa |
| Observed molecular weight | 52 kDa |
| GenBank accession number | BC006552 |
| Gene Symbol | ITFG2 |
| Gene ID (NCBI) | 55846 |
| RRID | AB_3742757 |
| Conjugate | Unconjugated |
| Form | |
| Form | Liquid |
| Purification Method | Antigen affinity Purification |
| UNIPROT ID | Q969R8 |
| Storage Buffer | PBS only{{ptg:BufferTemp}}7.3 |
| Storage Conditions | Store at -80°C. |
Background Information
Integrin-alpha FG-GAP repeat-containing protein 2 (ITFG2) is an immune-modulatory intracellular protein that modulates the fate of B cells and negatively regulates mTORC1 signaling (PMID: 23997217; 28199306). ITFG2 is highly expressed in the heart, which may be a novel strategy for the clinical management of myocardial infarction (PMID: 38848780).